Respiratory
Synergy Pharma Products
NEW LAUNCH
Tulobuterol Patch
Tulobuterol Patch is a long-acting transdermal bronchodilator designed for the management of obstructive airway diseases, including bronchial asthma, chronic and acute bronchitis, and emphysema. Administered once daily, the patch ensures 24-hour sustained release, offering effective symptom control—especially during night-time and early morning hours. Suitable for patients from 6 months of age and up, it is an ideal solution for those who have difficulty with oral or inhaled medications. With proven bioequivalence, excellent skin permeability, and a favorable safety profile, Tulobuterol Patch represents a reliable and patient-friendly treatment option in respiratory care.
Respiratory
Products available only from and to countries where there is no valid patent protection and according to the applicable law
Budesonide
Strength
1mg/2ml – 0.5mg/2ml – 0.25mg/2ml
200 mcg/actuation
Fluticasone
Strength
50 mcg/actuation
Mometasone
Strength
50 mcg/actuation
Salbutamol + Ipratropium
Strength
2.5mg + 0.5mg/2.5ml
Salmeterol + Fluticasone
Strength
- 25mcg + 125mcg
- 25mcg + 250mcg
- 50mcg + 250mcg
- 50mcg + 500mcg
Active Ingredient Under Development
Fluticasone
Strength
0.5mg/2ml – 2mg/2ml
Tiotropium
Strength
18 mcg/capsule
XTONIC
An innovave Medical Device, patented, with European certification from Cermet.
Xtonic®, a combination of sodium chloride and D-mannitol, in an optimal ratio, has been specifically designed for the inhalator treatment of Cystic Fibrosis, Primary ciliary dyskinesia and Bronchiectasis.
The combination of two effective ingredients in an optimal dosage to achieve a better tolerability and efficacy compared to hypertonic saline or mannitol, alone
OUR PRODUCTS
In addition to its focus on finished dosage forms, Synergy Swiss Pharma has also made significant expansions into various sectors. The company has established expertise in the fields of respiratory, cardiovascular, psychiatry, gastroenterology, and ophthalmology. Its portfolio includes a wide range of injectable products, encompassing both slow and fast-release formulations, with innovative applications for improved patient care.
Furthermore, Synergy Swiss Pharma has expanded its focus beyond pharmaceuticals and ventured into the realms of Medical Devices and Food Supplements. This diversification allows the company to provide a comprehensive range of healthcare solutions, catering to different aspects of patient well-being.
Frequently asked questions about respiratory products
Which respiratory products can Synergy Swiss Pharma supply?
The respiratory range covers the products listed on this page. Devices and dosage forms differ by product, and availability is confirmed with the manufacturing site for each market.
Are these products available worldwide?
Availability differs from market to market. Every request is checked against the regulatory and patent situation of the destination country before an offer is made.
How do you start an enquiry?
Send the product, the dosage form and strength, the destination market and the estimated annual volume to barbara@synergypharma.ch.
Related insights: Out-licensing a finished dosage form: how it works · Why source pharmaceutical products through Switzerland
NEW OPENING
MALAYSIA